Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Imlygic
Imlygic
ASCO Preview: Are Combo Treatments With Cancer-Killing Viruses Worth The Cost?
Forbes
Fri, 06/1/18 - 11:47 am
Amgen
ASCO 2018
Imlygic
Amgen wins quick EU approval for Imlygic, its first-in-class immuno-oncology drug
Fierce Pharma
Sun, 12/20/15 - 04:32 pm
Amgen
Europe
Imlygic
melanoma
Amgen's Imlygic May Not Boost Earnings But It Will Change Cancer Care
Forbes
Wed, 10/28/15 - 09:17 am
Amgen
Imlygic
T-Vec
blood cancer